Introduction to antibiotics (pertinent resp drugs) Flashcards
s. pneumoniae and s. aureus general resistance mechanism
reduced affinity of penicillin-binding proteins
gram-negative resistance (pseudomonas) to B-lactams occurs via what mechanisms…
B-lactamase production
what is empiric therapy
provide antimicrobial therapy to a symptomatic patient without identification of infecting organism. Must consider knowledge of microorganisms most likely to cause specific infection/symptoms
what does bacteriostatic mean
arrests growth and replication of bacteria (limits spread of infection)
i) In general, bacterial protein synthesis inhibitors
what is bactericidal
kills bacterial
examples–> aminoglycosides and fluoroquinolones
MOA of penicillins
inhibits the transpeptidation reaction, the last step in peptidoglycan synthesis. Cell wall composed of peptidoglycan which provides rigid mechanical stability. Peptidoglycan composed of two alternating sugars (N-acetylglucosamine and N-acetylmuramic acid). Five-amino-acid peptide linked to final N-acetylmuramic acid which terminates in D-alanyl-D-alanine. Penicillin binding proteins (PBPs) remove the terminal D-alanine in the process of forming the cross-link. B-lactams are structural analogs of D-Ala-D-Ala. B-lactams covalently bind PBPs preventing cross-linking ultimately leading to cell autolysis.
resistance mechanisms of bugs against penicillins
structural difference in PBPs (DRSP)
decreased PBP affinity for B-lactams (gram positives)
inability for drug to reach site of action (i.e. gram-negative organisms)
active efflux pumps
drug destruction and inactivation by B-lactamase (Gram negatives)
extended-spectrum
frequently administered with a B-lactamase inhibitor,
extends beyond gram-positive (s. pneumonia and s. pyogenes) to gram-negative (Haemophilus influenzae, Escherichia coli, Proteus mirabilis), Listeria monocytogenes, susceptible meningococci, enterococci
Aminopenicillins (ampicillin, amoxicillin)
ampicillin +/- sulbactam
amoxicillin +/- clavulanic acid
what are the anti-pseudomonal penicillins ?
extends spectrum to cover pseudomonas aeruginosa, enterobacter, and proteus spp. , klebsiella, and anaerobes!
includes pipercillin (+/- tazobactam- b-lactamase inhibitor)
what are the therapeutic uses of anti-pseudomonal penicillins (pipercillin)
: serious gram-negative infections, hospital acquired pneumonia, immunocompromised patients, bacteremia, burn infections, UTI
what are the adverse effects of penicillins
allergic rxns
anaphylaxis
interstitial nephritis
nausea/vomiting/mild/severe diarrhea
pseudomembranous colitis
true or false
cephalosporins have activity against methicillin resistant staph aureus (MRSA) , listeria, enterococci
false
none of them do!
cetriaxone
third generation cephalosporin
DOC for all forms of gonorrhea and severe lyme’s disease, meningitis
ceftazidime
third generation cephalosporin
covers pseudomonas
what are cephalosporins the DOC for
serious gram negative infections (klebsiella, enterobacter, proteus, providencia, serratia, haemophilus)
cefepime
Fourth generation cephalosporin
extends spectrum beyond third generation (useful in serious infections in hospitalized patients)
100% renal excretion
nosocomial infections
major Adverse effects of cephalosporins
1% risk of cross reactivity to penicillins (so be careful in patients who have penicillin allergy)
diarrhea
intolerance to alcohol
meropenem
carbapenem
ertapenem
carbapenem
spectrum of carbapenems
aerobics
anaerobics
gram positives (strep, enterococci, staph, listeria)
enterobacteriaceae
pseudomonas
acinetobacter
***Resistant to beta-lactamases
what are the adverse side effects of carbapenems
n/v
seizures
hypersensitivty
what are the 3 beta-lactamases inhibitors (combinations)
ampicillin- sulbactam
amoxicillin - clavulanic acid
pipercillin - tazobactam
what are the glycopeptides?
vancomycin
MOA of glycopeptides
inhibits cell wall synthesis binding with high affinity to D-alanyl-D-alanine terminal of cell wall precursor units. Due to large size, unable to penetrate outer membrane of gram-negative bacteria
what are the mechanisms of bacterial resistance to glycopeptides?
alteration of D-alanyl-D-alanine target to D-alanyl-D-lactate or D-alanyl-D-serine which binds glycopeptides poorly.
Intermediate resistance may occur if small proportion of cells growing with vancomycin present or if they have abnormally thick cell wall.
what is the spectrum of coverage of glycopeptides (Vancomycin)
broad gram positive coverage (s aureus (MRSA)
s. epidermidis (MRSE)
streptococci
bacillus
corynebacterium spp.
actinomyces
clostridium